Log in to save to my catalogue

Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer

Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10171177

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Pancreatic ductal adenocarcinoma (PDAC) is lethal in 88% of patients
1
, yet harbours mutation-derived T cell neoantigens that are suitable for vaccines
2
,
3
. Here in a phase I trial of adjuvant autogene cevumeran, an individualized neoantigen vaccine based on uridine mRNA–lipoplex nanoparticles, we synthesized mRNA neoantigen v...

Alternative Titles

Full title

Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10171177

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10171177

Other Identifiers

ISSN

0028-0836

E-ISSN

1476-4687

DOI

10.1038/s41586-023-06063-y

How to access this item